➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Mallinckrodt
Harvard Business School
Merck
Dow

Last Updated: October 24, 2021

DrugPatentWatch Database Preview

EXELTIS USA INC Company Profile


Email this page to a colleague

« Back to Dashboard

Summary for EXELTIS USA INC
International Patents:42
US Patents:5
Tradenames:3
Ingredients:3
NDAs:3

Drugs and US Patents for EXELTIS USA INC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Exeltis Usa Inc TYBLUME ethinyl estradiol; levonorgestrel TABLET;ORAL 209405-001 Mar 30, 2020 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial
Exeltis Usa Inc ESTRASORB estradiol hemihydrate EMULSION;TOPICAL 021371-001 Oct 9, 2003 DISCN Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial
Exeltis Usa Inc SLYND drospirenone TABLET;ORAL 211367-001 May 23, 2019 RX Yes Yes 10,603,281 ⤷  Free Forever Trial ⤷  Free Forever Trial
Exeltis Usa Inc SLYND drospirenone TABLET;ORAL 211367-001 May 23, 2019 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial
Exeltis Usa Inc SLYND drospirenone TABLET;ORAL 211367-001 May 23, 2019 RX Yes Yes 9,603,860 ⤷  Free Forever Trial ⤷  Free Forever Trial
Exeltis Usa Inc SLYND drospirenone TABLET;ORAL 211367-001 May 23, 2019 RX Yes Yes 10,849,857 ⤷  Free Forever Trial Y ⤷  Free Forever Trial
Exeltis Usa Inc SLYND drospirenone TABLET;ORAL 211367-001 May 23, 2019 RX Yes Yes 10,179,140 ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for EXELTIS USA INC Drugs

Country Patent Number Estimated Expiration
World Intellectual Property Organization (WIPO) 2012000981 ⤷  Free Forever Trial
Brazil 122019008317 ⤷  Free Forever Trial
Eurasian Patent Organization 201291372 ⤷  Free Forever Trial
South Korea 20210013663 ⤷  Free Forever Trial
South Korea 20130048227 ⤷  Free Forever Trial
Canada 2803721 ⤷  Free Forever Trial
European Patent Office 2588114 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration

Supplementary Protection Certificates for EXELTIS USA INC Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0334429 97C0002 Belgium ⤷  Free Forever Trial PRODUCT NAME: ESTRADIOL; NAT. REGISTRATION NO/DATE: NL 18978 19960731; FIRST REGISTRATION: SE - 11783 19930305
0402407 97C0005 Belgium ⤷  Free Forever Trial PRODUCT NAME: ESTRADIOL HEMIHYDRAAT; NAT. REGISTRATION NO/DATE: 298 IS 190 F 15 19960806; FIRST REGISTRATION: GB PL/0053/0241 19950711
2588114 C202030026 Spain ⤷  Free Forever Trial PRODUCT NAME: DROSPIRENONA; NATIONAL AUTHORISATION NUMBER: 84603-SE/H/1869/001/DC; DATE OF AUTHORISATION: 20191025; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): 61678; DATE OF FIRST AUTHORISATION IN EEA: 20191016
0285237 95C0008 Belgium ⤷  Free Forever Trial PRODUCT NAME: ESTRADIOL, HEMIHYDRATE; NAT. REGISTRATION NO/DATE: NL 19489 19941107; FIRST REGISTRATION: FR - NL 19489 19941107
1453521 CA 2016 00016 Denmark ⤷  Free Forever Trial PRODUCT NAME: LEVONORGESTREL OG ETHINYLOESTRADIOL; NAT. REG. NO/DATE: 56336 20151105; FIRST REG. NO/DATE: SK 17/0017/15-S 20150211
0770388 09C0018 France ⤷  Free Forever Trial PRODUCT NAME: ESTRADIOL VALERATE; DIENOGEST; NAT. REGISTRATION NO/DATE: NL35170 20081210; FIRST REGISTRATION: BE327792 20081103
1453521 C 2015 029 Romania ⤷  Free Forever Trial PRODUCT NAME: LEVONORGESTREL SI ETINILESTRADIOL; NATIONAL AUTHORISATION NUMBER: RO 7793/2015/001; DATE OF NATIONAL AUTHORISATION: 20150612; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): SK. 17/0017/15-S; DATE OF FIRST AUTHORISATION IN EEA: 20150129
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Medtronic
Johnson and Johnson
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.